Showing results (191-200 of 672) with videos related to

Sort By:
Pageof 68
Pharmacological Research|May 11, 2024
Decreased circulating IPA levels identify subjects with metabolic comorbidities: A multi-omics studyMarta Ballanti, Lorenzo Antonetti, Maria Mavilio, et al.
Computational and Structural Biotechnology Journal|November 15, 2021
Lipidomics and metabolomics signatures of SARS-CoV-2 mediators/receptors in peripheral leukocytes, jejunum and colonJordi Mayneris-Perxachs, José Maria Moreno-Navarrete, Marta Ballanti, et al.
ACS Chemical Biology|January 7, 2017
Inactivation of the Nuclear Orphan Receptor COUP-TFII by Small ChemicalsRémy Le Guével, Frédérik Oger, Celia P Martinez-Jimenez, et al.
Journal of Hepatology|July 8, 2018
The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesisMaheul Ploton, Claire Mazuy, Céline Gheeraert, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 29, 2003
Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammationChristophe Blanquart, Olivier Barbier, Jean Charles Fruchart, et al.
Atherosclerosis|October 31, 2025
Not all fibrates are made equal: Learning from biology and clinical trialsAlberto Zambon, Bart Staels, Michel Farnier, et al.
Nature Reviews. Cardiology|April 14, 2017
Monocytes and macrophages in abdominal aortic aneurysmJuliette Raffort, Fabien Lareyre, Marc Clément, et al.
The Journal of Biological Chemistry|July 16, 2002
Peroxisome proliferator-activated receptor alpha (PPARalpha ) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genesChristophe Blanquart, Olivier Barbier, Jean-Charles Fruchart, et al.
Biochemical and Biophysical Research Communications|June 5, 2004
Different ways to regulate the PPARalpha stabilityChristophe Blanquart, Roxane Mansouri, Jean-Charles Fruchart, et al.
Pageof 68